Financhill
Sell
38

CUE Quote, Financials, Valuation and Earnings

Last price:
$1.03
Seasonality move :
-5.06%
Day range:
$0.99 - $1.09
52-week range:
$0.45 - $3.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.32x
P/B ratio:
2.56x
Volume:
623.8K
Avg. volume:
489.5K
1-year change:
-62.59%
Market cap:
$64.9M
Revenue:
$5.5M
EPS (TTM):
-$0.91

Earnings Data

Next earnings date for CUE
Apr 08
2025
Most recent earnings per share
-$0.17
Beat by $0.02
(Nov 14/2024)
Consensus Estimate
-$0.19
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CUE Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2024 Q4 $1.7M -- -- -$0.15 --
11/14/2024 Q3 $1.5M $3.3M -$0.17 -$0.19 $0.02
08/19/2024 Q2 $1.3M $2.7M -$0.20 -$0.28 $0.08
05/09/2024 Q1 $1.2M $1.7M -$0.25 -$0.29 $0.04
03/21/2024 Q4 $1.6M $1.8M -$0.29 -$0.28 -$0.01
11/09/2023 Q3 -- -- -$0.24 -$0.34 $0.10
08/09/2023 Q2 -- -- -$0.29 -$0.31 $0.02
05/09/2023 Q1 -- -- -$0.29 -$0.29 --
03/21/2023 Q4 -- -- -$0.38 -$0.31 -$0.07
11/14/2022 Q3 -- -- -$0.31 -$0.38 $0.07
08/04/2022 Q2 -- -- -$0.37 -$0.40 $0.03
05/10/2022 Q1 -- -- -$0.44 -$0.42 -$0.02
03/16/2022 Q4 -- -- -$0.25 -$0.41 $0.16
11/09/2021 Q3 -- -- -$0.41 -$0.37 -$0.04
08/17/2021 Q2 -- -- -$0.33 -$0.40 $0.07
05/17/2021 Q1 -- -- -$0.41 -$0.36 -$0.06
03/16/2021 Q4 -- -- -$0.36 -$0.35 -$0.01
11/17/2020 Q3 -- -- -$0.34 -$0.38 $0.04
08/31/2020 Q2 -- -- -$0.38 -$0.43 $0.05
05/19/2020 Q1 -- -- -$0.48 -$0.37 -$0.11
03/17/2020 Q4 -- -- -$0.37 -$0.44 $0.07
11/12/2019 Q3 -- -- -$0.31 -$0.44 $0.13
08/08/2019 Q2 -- -- -$0.46 -$0.56 $0.10
05/08/2019 Q1 -- -- -$0.54 -$0.40 -$0.14
03/14/2019 Q4 -- -- -$0.58 -$0.40 -$0.18
11/13/2018 Q3 -- -- -$0.62 -- --
08/13/2018 Q2 -- -- -$0.36 -- --
05/14/2018 Q1 -- -- -$0.37 -- --
12/31/2017 Q4 -- -- -$0.51 -- --
09/30/2017 Q3 -- -- -$0.24 -- --
06/30/2017 Q2 -- -- -$0.21 -- --
03/31/2017 Q1 -- -- -$0.16 -- --
12/31/2016 Q4 -- -- -$0.14 -- --
09/30/2016 Q3 -- -- -$0.10 -- --

Cue Biopharma Earnings Questions

  • How Much did Cue Biopharma Generate in Revenue Last Quarter?

    Cue Biopharma reported $3.3M worth of top line sales in its most recent quarter.

  • Did Cue Biopharma Beat Earnings Last Quarter?

    Cue Biopharma announced earnings per share of -$0.17 which represents a beat of analyst forecast a -$0.19 per share.

  • Is Cue Biopharma Profitable?

    Cue Biopharma reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Cue Biopharma EPS Next Year?

    Cue Biopharma's earnings are forecast to decrease from -$1.11 per share to -$1.16 per share next year representing a decrease of -31.98%.

  • When is Cue Biopharma's Earnings Date?

    Cue Biopharma's next earnings date is April 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock